Imatinib mesylate in myelofibrosis: Preliminary results show early sustained improvements in platelet counts and splenomegaly.

A Y L Ho, S Lim, K Fishlock, T H Yang, N Westwood, S Devereux, A Pagliuca, G J Mufti

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	3155
Number of pages	1
Journal	Blood
Volume	100
Issue number	11
Publication status	Published - 2002
Event	44th Annual Meeting of the American-Society-of-Hematology - PHILADELPHIA, PENNSYLVANIA Duration: 1 Jan 2002 → …

Cite this

@article{9064af07b72c48969ed309c9762eb7ab,

title = "Imatinib mesylate in myelofibrosis: Preliminary results show early sustained improvements in platelet counts and splenomegaly.",

author = "Ho, {A Y L} and S Lim and K Fishlock and Yang, {T H} and N Westwood and S Devereux and A Pagliuca and Mufti, {G J}",

year = "2002",

language = "English",

volume = "100",

pages = "3155",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "11",

note = "44th Annual Meeting of the American-Society-of-Hematology ; Conference date: 01-01-2002",

}

TY - JOUR

T1 - Imatinib mesylate in myelofibrosis: Preliminary results show early sustained improvements in platelet counts and splenomegaly.

AU - Ho, A Y L

AU - Lim, S

AU - Fishlock, K

AU - Yang, T H

AU - Westwood, N

AU - Devereux, S

AU - Pagliuca, A

AU - Mufti, G J

PY - 2002

Y1 - 2002

M3 - Meeting abstract

SN - 1528-0020

VL - 100

SP - 3155

JO - Blood

JF - Blood

IS - 11

T2 - 44th Annual Meeting of the American-Society-of-Hematology

Y2 - 1 January 2002

ER -